|
2017-09-27 |
2017-09-25 |
S
Sale
|
MOORE TIMOTHY L.
EVP, Technical Operations
|
4,228
-8.5%
179.66
USD 759,619
|
4,228
-8.5%
|
179.66
|
USD 759,619
|
|
|
2017-09-27 |
2017-09-25 |
S
Sale
|
Wiezorek Jeffrey
SVP Clinical Development
|
5,283
-17.0%
179.66
USD 949,164
|
5,283
-17.0%
|
179.66
|
USD 949,164
|
|
|
2017-09-27 |
2017-09-25 |
S
Sale
|
JENKINSON PAUL L
Chief Financial Officer
|
948
-9.1%
179.66
USD 170,321
|
948
-9.1%
|
179.66
|
USD 170,321
|
|
|
2017-09-27 |
2017-09-25 |
S
Sale
|
BUTITTA CYNTHIA M
Chief Operating Officer
|
4,228
-3.4%
179.66
USD 759,619
|
4,228
-3.4%
|
179.66
|
USD 759,619
|
|
|
2017-09-27 |
2017-09-25 |
S
Sale
|
Belldegrun Arie
Chairman, President and CEO
Executive Director
|
26,347
-19.4%
179.66
USD 4,733,605
|
26,347
-19.4%
|
179.66
|
USD 4,733,605
|
|
|
2017-09-27 |
2017-09-25 |
S
Sale
|
Kim Helen Susan
EVP, Business Development
|
3,171
-12.8%
179.66
USD 569,714
|
3,171
-12.8%
|
179.66
|
USD 569,714
|
|
|
2017-09-27 |
2017-09-25 |
S
Sale
|
Tomasello Shawn
Chief Commercial Officer
|
4,203
-6.4%
179.66
USD 755,127
|
4,203
-6.4%
|
179.66
|
USD 755,127
|
|
|
2017-09-27 |
2017-09-25 |
S
Sale
|
Chang David D
EVP, R&D, Chief Medical Off.
|
7,927
-12.1%
179.66
USD 1,424,196
|
7,927
-12.1%
|
179.66
|
USD 1,424,196
|
|
|
2017-08-14 |
2017-08-10 |
PS
Planned sale
|
BUTITTA CYNTHIA M
Chief Operating Officer
|
5,800
-4.7%
121.03
USD 701,974
|
5,800
-4.7%
|
121.03
|
USD 701,974
|
|
|
2017-08-14 |
2017-08-10 |
PS
Planned sale
|
BUTITTA CYNTHIA M
Chief Operating Officer
|
9,200
-6.9%
120.52
USD 1,108,784
|
9,200
-6.9%
|
120.52
|
USD 1,108,784
|
|
|
2017-08-14 |
2017-08-10 |
PS
Planned sale
|
Kim Helen Susan
EVP, Business Development
|
6,251
-25.1%
120.09
USD 750,683
|
6,251
-25.1%
|
120.09
|
USD 750,683
|
|
|
2017-08-10 |
2017-08-08 |
PS
Planned sale
|
Kim Helen Susan
EVP, Business Development
|
13,274
-41.6%
121.37
USD 1,611,065
|
13,274
-41.6%
|
121.37
|
USD 1,611,065
|
|
|
2017-08-10 |
2017-08-08 |
PS
Planned sale
|
Kim Helen Susan
EVP, Business Development
|
31,165
-49.4%
120.40
USD 3,752,266
|
31,165
-49.4%
|
120.40
|
USD 3,752,266
|
|
|
2017-08-10 |
2017-08-08 |
PS
Planned sale
|
Kim Helen Susan
EVP, Business Development
|
18,936
-23.1%
119.94
USD 2,271,184
|
18,936
-23.1%
|
119.94
|
USD 2,271,184
|
|
|
2017-08-10 |
2017-08-08 |
PS
Planned sale
|
Kim Helen Susan
EVP, Business Development
|
3,800
-4.4%
118.61
USD 450,718
|
3,800
-4.4%
|
118.61
|
USD 450,718
|
|
|
2017-08-10 |
2017-08-08 |
PS
Planned sale
|
Kim Helen Susan
EVP, Business Development
|
1,700
-1.9%
117.27
USD 199,359
|
1,700
-1.9%
|
117.27
|
USD 199,359
|
|
|
2017-08-10 |
2017-08-08 |
PS
Planned sale
|
Kim Helen Susan
EVP, Business Development
|
11,074
-11.2%
115.02
USD 1,273,731
|
11,074
-11.2%
|
115.02
|
USD 1,273,731
|
|
|
2017-08-04 |
2017-08-03 |
PS
Planned sale
|
MOORE TIMOTHY L.
EVP, Technical Operations
|
5,131
-9.4%
110.05
USD 564,667
|
5,131
-9.4%
|
110.05
|
USD 564,667
|
|
|
2017-08-04 |
2017-08-03 |
PS
Planned sale
|
MOORE TIMOTHY L.
EVP, Technical Operations
|
869
-1.6%
110.10
USD 95,677
|
869
-1.6%
|
110.10
|
USD 95,677
|
|
|
2017-08-03 |
2017-08-01 |
PS
Planned sale
|
MOORE TIMOTHY L.
EVP, Technical Operations
|
321
-0.6%
109.35
USD 35,101
|
321
-0.6%
|
109.35
|
USD 35,101
|
|
|
2017-08-03 |
2017-08-01 |
PS
Planned sale
|
MOORE TIMOTHY L.
EVP, Technical Operations
|
3,771
-7.0%
108.27
USD 408,286
|
3,771
-7.0%
|
108.27
|
USD 408,286
|
|
|
2017-08-03 |
2017-08-01 |
PS
Planned sale
|
MOORE TIMOTHY L.
EVP, Technical Operations
|
5,431
-9.2%
107.58
USD 584,267
|
5,431
-9.2%
|
107.58
|
USD 584,267
|
|
|
2017-08-03 |
2017-08-01 |
PS
Planned sale
|
MOORE TIMOTHY L.
EVP, Technical Operations
|
2,477
-4.0%
106.85
USD 264,667
|
2,477
-4.0%
|
106.85
|
USD 264,667
|
|
|
2017-08-01 |
2017-07-31 |
PS
Planned sale
|
Kim Helen Susan
EVP, Business Development
|
672
-3.5%
111.60
USD 74,995
|
672
-3.5%
|
111.60
|
USD 74,995
|
|
|
2017-08-01 |
2017-07-31 |
PS
Planned sale
|
Kim Helen Susan
EVP, Business Development
|
2,725
-12.4%
110.55
USD 301,249
|
2,725
-12.4%
|
110.55
|
USD 301,249
|
|
|
2017-08-01 |
2017-07-31 |
PS
Planned sale
|
Kim Helen Susan
EVP, Business Development
|
7,448
-25.2%
109.74
USD 817,344
|
7,448
-25.2%
|
109.74
|
USD 817,344
|
|
|
2017-08-01 |
2017-07-31 |
PS
Planned sale
|
Kim Helen Susan
EVP, Business Development
|
15,804
-34.9%
108.75
USD 1,718,685
|
15,804
-34.9%
|
108.75
|
USD 1,718,685
|
|
|
2017-07-11 |
2017-07-10 |
PS
Planned sale
|
BUTITTA CYNTHIA M
Chief Operating Officer
Officer
|
5,000
-4.1%
105.50
USD 527,500
|
5,000
-4.1%
|
105.50
|
USD 527,500
|
|
|
2017-07-11 |
2017-07-10 |
PS
Planned sale
|
BUTITTA CYNTHIA M
Chief Operating Officer
Officer
|
1,100
-0.9%
102.81
USD 113,091
|
1,100
-0.9%
|
102.81
|
USD 113,091
|
|
|
2017-07-11 |
2017-07-10 |
PS
Planned sale
|
BUTITTA CYNTHIA M
Chief Operating Officer
Officer
|
5,553
-4.3%
102.19
USD 567,461
|
5,553
-4.3%
|
102.19
|
USD 567,461
|
|
|
2017-07-11 |
2017-07-10 |
PS
Planned sale
|
BUTITTA CYNTHIA M
Chief Operating Officer
Officer
|
3,347
-2.5%
101.06
USD 338,248
|
3,347
-2.5%
|
101.06
|
USD 338,248
|
|
|
2017-07-06 |
2017-07-03 |
PS
Planned sale
|
Wiezorek Jeffrey
SVP Clinical Development
Officer
|
1,201
-5.4%
104.76
USD 125,817
|
1,201
-5.4%
|
104.76
|
USD 125,817
|
|
|
2017-07-06 |
2017-07-03 |
PS
Planned sale
|
Wiezorek Jeffrey
SVP Clinical Development
Officer
|
8,799
-28.3%
104.26
USD 917,384
|
8,799
-28.3%
|
104.26
|
USD 917,384
|
|
|
2017-06-26 |
2017-06-26 |
S
Sale
|
WITTE OWEN N.
|
12,500
-14.1%
100.60
USD 1,257,500
|
12,500
-14.1%
|
100.60
|
USD 1,257,500
|
|
|
2017-06-27 |
2017-06-23 |
PS
Planned sale
|
BUTITTA CYNTHIA M
Chief Operating Officer
|
2,050
-1.8%
101.19
USD 207,440
|
2,050
-1.8%
|
101.19
|
USD 207,440
|
|
|
2017-06-27 |
2017-06-23 |
PS
Planned sale
|
BUTITTA CYNTHIA M
Chief Operating Officer
|
2,950
-2.5%
100.54
USD 296,593
|
2,950
-2.5%
|
100.54
|
USD 296,593
|
|
|
2017-06-26 |
2017-06-23 |
PS
Planned sale
|
WITTE OWEN N.
|
12,500
-12.3%
100.00
USD 1,250,000
|
12,500
-12.3%
|
100.00
|
USD 1,250,000
|
|
|
2017-06-16 |
2017-06-16 |
S
Sale
|
CHAMPSI FARAH
|
5,450
-100.0%
88.11
USD 480,200
|
5,450
-100.0%
|
88.11
|
USD 480,200
|
|
|
2017-06-16 |
2017-06-14 |
S
Sale
|
CHAMPSI FARAH
|
15,000
-19.1%
90.40
USD 1,356,000
|
15,000
-19.1%
|
90.40
|
USD 1,356,000
|
|
|
2017-06-16 |
2017-06-14 |
S
Sale
|
Ruchefsky Steven B
|
20,000
-8.9%
89.48
USD 1,789,574
|
20,000
-8.9%
|
89.48
|
USD 1,789,574
|
|
|
2017-06-12 |
2017-06-09 |
PS
Planned sale
|
BUTITTA CYNTHIA M
Chief Operating Officer
|
400
-0.3%
91.08
USD 36,432
|
400
-0.3%
|
91.08
|
USD 36,432
|
|
|
2017-06-12 |
2017-06-09 |
PS
Planned sale
|
BUTITTA CYNTHIA M
Chief Operating Officer
|
1,698
-1.4%
89.76
USD 152,412
|
1,698
-1.4%
|
89.76
|
USD 152,412
|
|
|
2017-06-12 |
2017-06-09 |
PS
Planned sale
|
BUTITTA CYNTHIA M
Chief Operating Officer
|
4,100
-3.3%
89.09
USD 365,269
|
4,100
-3.3%
|
89.09
|
USD 365,269
|
|
|
2017-06-12 |
2017-06-09 |
PS
Planned sale
|
BUTITTA CYNTHIA M
Chief Operating Officer
|
2,502
-2.0%
87.80
USD 219,676
|
2,502
-2.0%
|
87.80
|
USD 219,676
|
|
|
2017-06-12 |
2017-06-09 |
PS
Planned sale
|
BUTITTA CYNTHIA M
Chief Operating Officer
|
900
-0.7%
86.42
USD 77,778
|
900
-0.7%
|
86.42
|
USD 77,778
|
|
|
2017-06-12 |
2017-06-09 |
PS
Planned sale
|
BUTITTA CYNTHIA M
Chief Operating Officer
|
400
-0.3%
84.81
USD 33,924
|
400
-0.3%
|
84.81
|
USD 33,924
|
|
|
2017-06-09 |
2017-06-08 |
S
Sale
|
DOUMANI ROY
|
5,000
-3.2%
84.53
USD 422,634
|
5,000
-3.2%
|
84.53
|
USD 422,634
|
|
|
2017-06-09 |
2017-06-07 |
S
Sale
|
DOUMANI ROY
|
10,000
-6.1%
84.46
USD 844,621
|
10,000
-6.1%
|
84.46
|
USD 844,621
|
|
|
2017-06-05 |
2017-06-01 |
PS
Planned sale
|
Kim Helen Susan
EVP, Business Development
|
2,400
-11.4%
72.45
USD 173,880
|
2,400
-11.4%
|
72.45
|
USD 173,880
|
|
|
2017-05-10 |
2017-05-10 |
B
Purchase
|
JENKINSON PAUL L
Chief Financial Officer
Officer
|
3,000
+inf%
72.59
USD 217,770
|
3,000
+inf%
|
72.59
|
USD 217,770
|
|
|
2017-05-10 |
2017-05-10 |
PP
Planned purchase
|
JENKINSON PAUL L
Chief Financial Officer
Officer
|
450
+6.4%
72.57
USD 32,657
|
450
+6.4%
|
72.57
|
USD 32,657
|
|
|
2017-05-11 |
2017-05-09 |
B
Purchase
|
Nussbaum Ran
Non-Executive Director
|
2,632
+inf%
68.94
USD 181,450
|
2,632
+inf%
|
68.94
|
USD 181,450
|
|
|
2017-05-11 |
2017-05-09 |
B
Purchase
|
Nussbaum Ran
Non-Executive Director
|
1,029
+inf%
69.17
USD 71,176
|
1,029
+inf%
|
69.17
|
USD 71,176
|
|
|
2017-05-11 |
2017-05-09 |
B
Purchase
|
Nussbaum Ran
Non-Executive Director
|
2,651
+inf%
69.17
USD 183,370
|
2,651
+inf%
|
69.17
|
USD 183,370
|
|
|
2017-05-11 |
2017-05-09 |
B
Purchase
|
Nussbaum Ran
Non-Executive Director
|
3,520
+inf%
69.17
USD 243,478
|
3,520
+inf%
|
69.17
|
USD 243,478
|
|
|
2017-05-10 |
2017-05-09 |
B
Purchase
|
Ruchefsky Steven B
Non-Executive Director
|
1,400
+0.6%
69.50
USD 97,300
|
1,400
+0.6%
|
69.50
|
USD 97,300
|
|
|
2017-05-09 |
2017-05-09 |
B
Purchase
|
Belldegrun Arie
Chairman, President and CEO
Executive Director
|
17,000
+24.8%
68.57
USD 1,165,690
|
17,000
+24.8%
|
68.57
|
USD 1,165,690
|
|
|
2017-05-09 |
2017-05-09 |
B
Purchase
|
BONDERMAN DAVID
Non-Executive Director
|
3,815
+0.2%
70.15
USD 267,622
|
3,815
+0.2%
|
70.15
|
USD 267,622
|
|
|
2017-05-09 |
2017-05-09 |
B
Purchase
|
BONDERMAN DAVID
Non-Executive Director
|
46,185
+2.0%
68.84
USD 3,179,375
|
46,185
+2.0%
|
68.84
|
USD 3,179,375
|
|
|
2017-05-03 |
2017-05-01 |
PS
Planned sale
|
Chang David D
EVP, R&D, Chief Medical Off.
Officer
|
300
-0.6%
83.36
USD 25,008
|
300
-0.6%
|
83.36
|
USD 25,008
|
|
|
2017-05-03 |
2017-05-01 |
PS
Planned sale
|
Chang David D
EVP, R&D, Chief Medical Off.
Officer
|
5,905
-10.5%
82.60
USD 487,753
|
5,905
-10.5%
|
82.60
|
USD 487,753
|
|
|
2017-05-03 |
2017-05-01 |
PS
Planned sale
|
Chang David D
EVP, R&D, Chief Medical Off.
Officer
|
13,795
-19.7%
81.84
USD 1,128,983
|
13,795
-19.7%
|
81.84
|
USD 1,128,983
|
|
|
2017-05-03 |
2017-05-01 |
PS
Planned sale
|
Kim Helen Susan
EVP, Business Development
Officer
|
2,400
-11.4%
82.12
USD 197,088
|
2,400
-11.4%
|
82.12
|
USD 197,088
|
|
|
2017-05-01 |
2017-04-28 |
S
Sale
|
CHAMPSI FARAH
Non-Executive Director
|
2,617
-34.5%
82.59
USD 216,138
|
2,617
-34.5%
|
82.59
|
USD 216,138
|
|
|
2017-05-01 |
2017-04-27 |
S
Sale
|
CHAMPSI FARAH
Non-Executive Director
|
16,551
-68.6%
82.77
USD 1,369,926
|
16,551
-68.6%
|
82.77
|
USD 1,369,926
|
|
|
2017-04-26 |
2017-04-26 |
S
Sale
|
CHAMPSI FARAH
|
200
-0.8%
83.06
USD 16,612
|
200
-0.8%
|
83.06
|
USD 16,612
|
|
|
2017-04-26 |
2017-04-26 |
S
Sale
|
CHAMPSI FARAH
|
51,112
-67.8%
82.72
USD 4,227,985
|
51,112
-67.8%
|
82.72
|
USD 4,227,985
|
|
|
2017-04-27 |
2017-04-25 |
PS
Planned sale
|
BUTITTA CYNTHIA M
Chief Operating Officer
|
3,742
-3.1%
82.87
USD 310,100
|
3,742
-3.1%
|
82.87
|
USD 310,100
|
|
|
2017-04-27 |
2017-04-25 |
PS
Planned sale
|
BUTITTA CYNTHIA M
Chief Operating Officer
|
5,545
-4.4%
82.14
USD 455,466
|
5,545
-4.4%
|
82.14
|
USD 455,466
|
|
|
2017-04-27 |
2017-04-25 |
PS
Planned sale
|
BUTITTA CYNTHIA M
Chief Operating Officer
|
5,713
-4.3%
80.89
USD 462,125
|
5,713
-4.3%
|
80.89
|
USD 462,125
|
|
|
2017-04-26 |
2017-04-25 |
S
Sale
|
CHAMPSI FARAH
|
15,316
-16.9%
83.29
USD 1,275,670
|
15,316
-16.9%
|
83.29
|
USD 1,275,670
|
|
|
2017-04-26 |
2017-04-25 |
S
Sale
|
CHAMPSI FARAH
|
31,467
-25.7%
82.56
USD 2,597,916
|
31,467
-25.7%
|
82.56
|
USD 2,597,916
|
|
|
2017-04-26 |
2017-04-24 |
S
Sale
|
CHAMPSI FARAH
|
25,818
-17.4%
82.34
USD 2,125,854
|
25,818
-17.4%
|
82.34
|
USD 2,125,854
|
|
|
2017-04-17 |
2017-04-17 |
S
Sale
|
CHAMPSI FARAH
|
100
-0.1%
83.06
USD 8,306
|
100
-0.1%
|
83.06
|
USD 8,306
|
|
|
2017-04-17 |
2017-04-17 |
S
Sale
|
CHAMPSI FARAH
|
43,001
-22.5%
82.48
USD 3,546,722
|
43,001
-22.5%
|
82.48
|
USD 3,546,722
|
|
